Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease (Q80347494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Schinzari F

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Armuzzi A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

De Pascalis B

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tesauro M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Melina D

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Cardillo C

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

16 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

70-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

The immunological and genetic basis of inflammatory bowel disease

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Cytokine-based therapies for Crohn's disease--new paradigms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Infliximab maintenance therapy for fistulizing Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Endothelial function: cardiac events

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Acute systemic inflammation impairs endothelium-dependent dilatation in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Length, force, and Ca(2+)-troponin C affinity in cardiac and slow skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

A tale of two diseases: atherosclerosis and rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

The fundamental basis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

The potential biological and clinical significance of the soluble tumor necrosis factor receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Intravascular tumor necrosis factor α blockade reverses endothelial dysfunction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100229

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17507924%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference